Global TB Drug Pipeline, January 2007 (Figure: Kindly provided by STOP TB Partnership Working Group on New TB Drugs)

<p>BTTTRI, Beijing Tuberculosis and Thoracic Tumor Research Institute; CDC, Centers for Disease Control and Prevention; DMID, Division of Microbiology and Infectious Diseases; ITR, Institute for Tuberculosis Research; KRICT, Korean Research Institute of Chemical Technology; NERC, Natural Environment Research Council; NIAID, National Institute of Allergy and Infectious Disease; NIH, National Institutes of Health; TAACF, Tuberculosis Antimicrobial Acquisition and Coordinating Facility; TBRU, Tuberculosis Research Unit; TBTC, Tuberculosis Trials Consortium; TDR, Special Programme for Research and Training in Tropical Diseases; WHO, World Health Organization</p

Xpert testing strategies and MTB detection.

<p>Xpert testing strategies and MTB detection.</p

Key changes between 2021 and 2014 TPPs for peripheral TB drug-susceptibility testing.

Key changes between 2021 and 2014 TPPs for peripheral TB drug-susceptibility testing.</p